Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 121 | MSFT | MICROSOFT CORP | Technology | 3,948.0 | $1.5M | 0.40% | +429.0 | +12.2% | $370.17 | +13.5% |
| 122 | MRNA | MODERNA INC | Healthcare | 28,656.0 | $1.5M | 0.40% | +5K | +23.5% | $50.80 | -5.2% |
| 123 | APH | AMPHENOL CORP | Technology | 11,414.0 | $1.4M | 0.40% | -2K | -17.8% | $126.35 | -3.6% |
| 124 | MELI | MERCADOLIBRE INC | Consumer Cyclical | 827.0 | $1.4M | 0.39% | -6.0 | -0.7% | $1729.02 | -9.6% |
| 125 | APP | APPLOVIN CORP | Technology | 3,491.0 | $1.4M | 0.38% | +447.0 | +14.7% | $398.00 | +23.2% |
| 126 | CTSH | COGNIZANT TECHNOLOGY SOLUTIO | Technology | 22,418.0 | $1.4M | 0.38% | NEW | — | $61.35 | -18.4% |
| 127 | DASH | DOORDASH INC | Communication Services | 9,152.0 | $1.4M | 0.38% | +2K | +25.4% | $150.15 | +8.1% |
| 128 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 383,763.0 | $1.3M | 0.37% | +73K | +23.5% | $3.51 | -1.3% |
| 129 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 33,462.0 | $1.3M | 0.37% | +6K | +23.5% | $40.23 | +2.0% |
| 130 | OCCI | OFS CREDIT COMPANY INC | Financial Services | 462,155.0 | $1.3M | 0.37% | +41K | +9.7% | $2.89 | +17.8% |
| 131 | AXON | AXON ENTERPRISE INC | Industrials | 3,109.0 | $1.3M | 0.36% | +583.0 | +23.1% | $424.69 | -6.1% |
| 132 | HOOD | ROBINHOOD MKTS INC | Financial Services | 18,033.0 | $1.2M | 0.34% | +5K | +38.3% | $69.30 | +10.2% |
| 133 | CVNA | CARVANA CO | Consumer Cyclical | 3,972.0 | $1.2M | 0.34% | -1K | -24.6% | $314.38 | -78.8% |
| 134 | ERAS | ERASCA INC | Healthcare | 75,746.0 | $1.2M | 0.34% | +2K | +2.5% | $16.18 | -37.1% |
| 135 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 12,987.0 | $1.2M | 0.33% | +2K | +23.5% | $92.38 | +4.0% |
| 136 | BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | 111,529.0 | $1.1M | 0.29% | +21K | +23.5% | $9.52 | -5.6% |
| 137 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 38,202.0 | $1.1M | 0.29% | +7K | +23.5% | $27.70 | +3.2% |
| 138 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 30,959.0 | $1.0M | 0.29% | +6K | +23.5% | $33.83 | -16.4% |
| 139 | NVAX | NOVAVAX INC | Healthcare | 128,505.0 | $1.0M | 0.29% | +24K | +23.5% | $8.14 | +11.6% |
| 140 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 1,707.0 | $1.0M | 0.28% | +325.0 | +23.5% | $592.98 | -4.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%